Evidence for the role of calcium and diacylglycerol as dual second messengers in thyrotropin-releasing hormone action: involvement of Ca+2.
The studies reported here were directed toward establishing the mechanism by which TRH acutely stimulates PRL secretion in GH3 pituitary cells. Studies of TRH stimulation of PRL secretion were conducted on a time scale which enables comparison with other reported rapid effects of TRH on GH3 cells. TRH stimulation of secretion was found to be extremely rapid in onset (less than or equal to 10 sec) and biphasic (phase I, 0-2 min; phase II, 5-60 min). The earliest (phase I) secretory response was observed to be independent of medium Ca+2 concentration or Ca+2 influx, but to be dependent on an intracellular Ca+2 pool. The phase II response to TRH was found to depend, in part, on medium Ca+2. The phase I response to TRH could be mimicked only by agents known to influence Ca+2 translocation in GH3 cells (60 mM K+, A23187, ionomycin, carbonyl cyanide p-trifluoromethoxyphenylhydrazone, and carbonyl cyanide m-chlorophenylhydrazone). These agents failed to promote sustained PRL release characteristic of phase II. It is concluded that the ability of TRH to rapidly stimulate PRL secretion (phase I) is correlated with its ability to rapidly promote a transient cytoplasmic Ca+2 concentration rise from an intracellular Ca+2 pool.
D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone / Q000494:pharmacology; D002259:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone / Q000494:pharmacology; D002460:Cell Line; D004075:Diglycerides / Q000378:metabolism*; D005711:Gallopamil / Q000494:pharmacology; D005989:Glycerides / Q000378:metabolism*; D010911:Pituitary Neoplasms / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology; D011388:Prolactin / Q000378:metabolism; D051381:Rats; D011956:Receptors, Cell Surface / Q000378:metabolism; D018025:Receptors, Thyrotropin-Releasing Hormone; D013973:Thyrotropin-Releasing Hormone / Q000502:physiology*; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
D004075:Diglycerides; D005989:Glycerides; D011956:Receptors, Cell Surface; D018025:Receptors, Thyrotropin-Releasing Hormone; D002259:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; D014660:Vasoactive Intestinal Peptide; D000001:Calcimycin; D005711:Gallopamil; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D011188:Potassium; D002118:Calcium